| Description |
1 online resource |
| Series |
Oxford Studies in European Law |
|
Oxford studies in European law.
|
| Contents |
Cover; Title Page; Copyright Page; Contents; Table of Cases; Table of Instruments and Legislation; List of Abbreviations; List of Contributors; 1. European Law and New Health Technologies: The Research Agenda; Part I. Setting the Scene; 2. The Defining Features of the European Union's Approach to Regulating New Health Technologies; 3. Fixed Points in a Changing Age? The Council of Europe, Human Rights, and the Regulation of New Health Technologies; 4. Mapping Science and New Health Technologies: In Search of a Definition |
|
A Regulator's Perspective: Jonathan Montgomery (formerly chair of the Human Genetics Commission)Part II. Legal Approaches to European Law and New Health Technologies; 5. Innovative Tissue Engineering and Its Regulation-The Search for Flexible Rules for Emerging Health Technologies; 6. Looking After the Orphans? Treatments for Rare Diseases, EU Law, and the Ethics of Costly Health Care; 7. Exclusions in Patent Law as an Indirect Form of Regulation for New Health Technologies in Europe; 8. New Health Technologies and Their Impact on EU Product Liability Regulations |
|
A Regulator's Perspective: Graeme Laurie (formerly chair of the Ethics and Governance Council of the UK Biobank)A Regulator's Perspective: Belén Crespo Sánchez-Eznarriaga (Director of Agencia Española de Medicamentos y Productos Sanitarios); Part III. Regulatory Theory, Regulatory Innovation, European Law, and New Health Technologies; 9. Risk, Legitimacy, and EU Regulation of Health Technologies; 10. Something Old, Something New, Something Borrowed: Emerging Health Technologies and the Continuing Role of Existing Regulations |
|
11. Science, Law, and the Medical-Industrial Complex in EU Pharmaceutical Regulation: The Deferiprone Controversy12. The Governance of Therapeutic Nanoproducts in the European Union-A Model for New Health Technology Regulation?; A Regulator's Perspective: Emily Jackson (formerly deputy chair of the Human Fertilisation and Embryology Authority); Part IV. New Techniques for Researching European Law and New Health Technologies; 13. Taking Technology Seriously: STS as a Human Rights Method; 14. Novel Rights-Based Approaches to Health Technologies |
|
15. Sociotechnical Innovation in Mental Health: Articulating Complexity16. Where the Wild Things Are: Xenotechnologies and European Hybrid Regulation; 17. When Sperm Cannot Travel: Experiences of UK Fertility Patients Seeking Treatment Abroad; A Regulator's Perspective: Mihalis Kritikos (formerly of the European Commission); Part V. Bringing it All Together; 18. A European Law of New Health Technologies?; Select Bibliography; Index; Footnotes; Chapter 02; Chapter 03; Chapter 04; Genetics; Chapter 05; Chapter 06; Chapter 07; Chapter 08; Legitimacy; Chapter 09; Chapter 10; Chapter 11 |
| Summary |
New health technologies promise great things but they also pose significant challenges for governments, particularly around safety concerns, effectiveness and value for money. This collection analyses the defining features of the relationship between EU law and new technologies, examining the roles of risk, rights, ethics and markets |
| Bibliography |
Includes bibliographical references and index |
| Notes |
English |
|
Print version record |
| Subject |
Medical technology -- Law and legislation -- European Union countries
|
|
Law.
|
|
Laws of Specific jurisdictions.
|
|
Medical and healthcare law.
|
|
Social law.
|
|
Medical technology -- Law and legislation
|
|
European Union countries
|
| Form |
Electronic book
|
| ISBN |
1299559182 |
|
9781299559189 |
|
0191748161 |
|
9780191748165 |
|
0191634859 |
|
9780191634857 |
|
0191634840 |
|
9780191634840 |
|
